Valuation : Olympus Corporation

Market Cap 2,190B 14.02B 12.08B 11.36B 10.38B 19.39B 1,325B 19.46B 133B 51.98B 680B 52.66B 51.51B P/E 2027 *
21x
P/E 2028 * 18.1x
Enterprise Value 2,272B 14.54B 12.53B 11.78B 10.77B 20.12B 1,374B 20.19B 138B 53.92B 705B 54.63B 53.43B EV / Sales 2027 *
2.11x
EV / Sales 2028 * 2.02x
Free-Float
94.58%
Yield 2027 *
1.5%
Yield 2028 * 1.56%
1 day-0.34%
1 week-4.09%
Current month-2.11%
1 month+14.06%
3 months+11.80%
6 months+52.38%
Current year+3.85%
1 week 2,040
Extreme 2040
2,154
1 month 1,843
Extreme 1843
2,210.5
Current year 1,302.5
Extreme 1302.5
2,210.5
1 year 1,302.5
Extreme 1302.5
2,210.5
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%-4.09%+10.10%+1.90% 14.04B
-0.75%-1.35%+24.60%+13.24% 227B
-1.60%-3.89%+3.72%-20.39% 146B
-0.85%-1.58%-21.45%+19.18% 130B
+1.81%+2.05%-55.42%-10.32% 69.27B
+0.13%-0.34%+11.07%+18.34% 51.82B
+0.49%-1.32%-17.44%-13.87% 50.45B
+0.59%-1.94%+17.17%+27.06% 42.53B
-1.01%-1.28%+33.64%+48.14% 40.22B
-1.55%+1.22%+120.58%+36.88% 32.95B
Average -0.31%-1.82%+12.66%+12.02% 80.38B
Weighted average by Cap. -0.53%-1.59%+6.72%+7.94%

Financials

2027 *2028 *
Net sales 1,079B 6.91B 5.95B 5.6B 5.11B 9.55B 653B 9.59B 65.62B 25.61B 335B 25.95B 25.38B 1,117B 7.15B 6.16B 5.79B 5.29B 9.89B 675B 9.92B 67.91B 26.5B 347B 26.85B 26.26B
Net income 105B 672M 579M 544M 497M 929M 63.47B 933M 6.38B 2.49B 32.57B 2.52B 2.47B 122B 779M 671M 631M 577M 1.08B 73.58B 1.08B 7.4B 2.89B 37.76B 2.93B 2.86B
Net Debt 81.71B 523M 450M 424M 387M 723M 49.41B 726M 4.97B 1.94B 25.36B 1.96B 1.92B 64.09B 410M 353M 332M 304M 567M 38.75B 569M 3.9B 1.52B 19.89B 1.54B 1.51B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-09-04 JP¥2,061.00 -0.34% 4,332,400
26-09-03 JP¥2,068.00 -0.84% 4,398,600
26-09-02 JP¥2,085.50 -2.07% 4,235,500
26-09-01 JP¥2,129.50 +1.14% 5,050,400
26-08-31 JP¥2,105.50 -2.02% 5,568,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,061.00JPY
Average target price
2,157.69JPY
Spread / Average Target
+4.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock